Skip to main content
SpringerLink
Log in

Decreased gallbladder response in leptin-deficient obese mice

  • Published:
Journal of Gastrointestinal Surgery

Abstract

Obesity is a major risk factor for gallstone formation, but the pathogenesis of this phenomenon remains unclear. Human data on gallbladder emptying are conflicting, and no animal data exist on the effect of obesity on gallbladder motility. Leptin, a hormone produced by adipocytes, is known to have central effects on neuropeptide Y and cholecystokinin, but the influence of leptin on the biliary effects of these hormones is unknown. Therefore we tested the hypothesis that leptin-deficient C57BL/6J-lepob obese mice would have decreased gallbladder responses to excitatory stimuli. Twelve-week-old lean control (C57BL/6J) (n = 22) and C57BL/6J-lepob obese (n = 20) female mice were fed a nonlithogenic diet. The mice were fasted overnight and underwent cholecystectomy. Whole gallbladders were placed in 3 ml muscle baths. After optimal length was determined with acetylcholine (10-5 mol/L, responses to increasing doses of neuropeptide Y (10-8 to 10-6 mol/L) and cholecystokinin-8 (10-10 to 10-7 mol/L) were measured. Student’s t test and two-way analysis of variance were used where appropriate. Results were expressed as Newtons per cross-sectional area. The lean control mice had significantly greater excitatory responses to acetylcholine than the obese mice (0.37 ± 0.05 vs. 0.16 ± 0.02, P < 0.01). The gallbladder responses were also greater when mice were treated with neuropeptide Y (10-8 mol/L: 0.00 ± 0.00 vs. 0.00 ± 0.00, NS; 10-7 mol/L: 0.12 ± 0.02 vs. 0.05 ± 0.01, P < 0.01; 10-6 mol/L: 0.26 ± 0.08 vs. 0.06 ± 0.01, P < 0.01) and cholecystokinin (10-10 mol/L: 0.27 ± 0.04 vs. 0.13 ± 0.02, P < 0.01; 10-9 mol/L: 0.59 ± 0.08 vs. 0.27 ± 0.04, P < 0.01; 10-8 mol/L: 0.80 ± 0.11 vs. 0.37 ± 0.05, P < 0.01; 10-7 mol/L: 0.86 ± 0.11 vs. 0.44 ± 0.06, P < 0.01). These data suggest that genetically obese, leptin-deficient mice have decreased responses to acetylcholine, neuropeptide Y, and cholecystokinin. We conclude that decreased gallbladder motility contributes to the increased incidence of gallstones associated with obesity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Graves EJ, Owings MF. 1995 Summary: National Hospital Discharge Survey. Advance Data From Vital and Health Statistics; No. 291. National Center for Health Statistics 1997.

  2. Nakeeb A, Goldblatt MI, Swartz-Basile DA, et al. The role of genetics in gallstone pathogenesis. Gastroenterology (in press).

  3. Carey MC. Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res 1978;19:945–955.

    PubMed  CAS  Google Scholar 

  4. Inui A. Feeding and body-weight regulation by hypothalamic neuropeptides—mediation of the actions of leptin. Trends Neurosci 1999;22;62–67.

    Article  PubMed  CAS  Google Scholar 

  5. Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425–432.

    Article  PubMed  CAS  Google Scholar 

  6. Swartz-Basile D, Choi S-H, Blaser C, et al. Gallbladder volume and composition in genetically obese mice. Gastroenterology 2000; 118:12.

    Article  Google Scholar 

  7. Goldblatt M, Choi S-H, Swartz-Basile D, et al. Cholesterol crystal formation in congenitally obese mice. Surg Forum 2000;51:1–2.

    CAS  Google Scholar 

  8. Mokdad A, Serdula M, Dietz W, et al. The spread of the obesity epidemic in the United States, 1991–1998. JAMA 1999;282:1519–1522.

    Article  PubMed  CAS  Google Scholar 

  9. Shaffer EA, Small DM. Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity. J Clin Invest 1977;59:828–840.

    Article  PubMed  CAS  Google Scholar 

  10. Amaral JF, Thompson WR. Gallbladder disease in the morbidly obese. Am J Surg 1985;149:551–557.

    Article  PubMed  CAS  Google Scholar 

  11. Hendel HW, Hojgaard L, Andersen T, et al. Fasting gall bladder volume and lithogenicity in relation to glucose tolerance, total and intra-abdominal fat masses in obese nondiabetic subjects. Int J Obes 1998;22:294–302.

    Article  CAS  Google Scholar 

  12. Palasciano G, Portincasa P, Belfiore A, et al. Gallbladder volume and emptying in diabetics: The role of neuropathy and obesity. J Intern Med 1992;231:123–127.

    PubMed  CAS  Google Scholar 

  13. Vezina WC, Paradis RL, Grace DM, et al. Increased volume and decreased emptying of the gallbladder in large (morbidly obese, tall normal, and muscular normal) people. Gastroenterology 1990;98:1000–1 007.

    PubMed  CAS  Google Scholar 

  14. Acalovschi M, Badea R. Ultrasonographic study of gallbladder emptying in obese patients. Int J Obes Relat Metab Disord 1992;16:313–315.

    PubMed  CAS  Google Scholar 

  15. Yanovski JA, Yanovski SZ. Recent advances in basic obesity research. JAMA 1999;282:1504–1506.

    Article  PubMed  CAS  Google Scholar 

  16. Halaas JL, Gajiwala KS, Maffei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995;269:543–546.

    Article  PubMed  CAS  Google Scholar 

  17. Attoub S, Levasseur S, Buyse M, et al. Physiological role of cholecystokinin B/gastrin receptor in leptin secretion. Endocrinology 1999; 140:4406–4410.

    Article  PubMed  CAS  Google Scholar 

  18. Fisher RS, Rock E, Malmud LS. Cholinergic effects on gallbladder emptying in humans. Gastroenterology 1985; 89:716–722.

    PubMed  CAS  Google Scholar 

  19. Parkman HP, Pagano AP, Ryan JP. Subtypes of muscarinic receptors regulating gallbladder cholinergic contractions. AmJ Physiol 1999;276:1243–1250.

    Google Scholar 

  20. Rohner-Jeanrenaud E, Jeanrenaud B. Central nervous system and body weight regulation. Ann Endocrinol 1997; 58:137–142.

    CAS  Google Scholar 

  21. Wilding JP, Gilbey SG, Bailey CJ, et al. Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse. Endocrinology 1993;132:1939–1944.

    Article  PubMed  CAS  Google Scholar 

  22. White BD, Martin RJ. Evidence for a central mechanism of obesity in the Zucker rat: Role of neuropeptide Y and leptin. Proc Soc Exp BiolMed 1997;214:222–232.

    CAS  Google Scholar 

  23. Vila E, Tabernero A, Fernandes F, Salaices M. Effect of neuropeptide Y on adrenergic and non-adrenergic, noncholinergic responses in the rat anococcygeus muscle. Br J Pharmacol 1992;107:66–72.

    PubMed  CAS  Google Scholar 

  24. Lillemoe KD, Webb TH, Pitt HA. Neuropeptide Y: A candidate neurotransmitter for biliary motility. J Surg Res 1988;45:254–260.

    Article  PubMed  CAS  Google Scholar 

  25. Hoyo Y, McGrath JC, Vila E. Evidence for Y1-receptor-mediated facilitatory, modulatory cotransmission by NPY in the rat anococcygeus muscle. J Pharmacol Exp Ther 2000;294:38–44.

    PubMed  CAS  Google Scholar 

  26. Barrachina MD, Martinez V, Wang L, et al. Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice. Proc Natl Acad Sci U S A 1997;94:10455–10460.

    Article  PubMed  CAS  Google Scholar 

  27. Nardone G, Ferber IA, Miller LJ. The integrity of the cholecystokinin receptor gene in gallbladder disease and obesity. Hepatology 1995;22:1751–1753.

    PubMed  CAS  Google Scholar 

  28. Xiao ZL, Chen Q, Amaral J, et al. CCK receptor dysfunction in muscle membranes from human gallbladders with cholesterol stones. AmJ Physiol 1999;276:G1401-G1407.

    CAS  Google Scholar 

  29. Ross PE, Butt AN, Gallacher C. Cholesterol absorption by the gall bladder. J Clin Pathol 1990;43:572–575.

    Article  PubMed  CAS  Google Scholar 

  30. Yu P, Chen Q, Harnett KM, et al. Direct G protein activation reverses impaired CCK signaling in human gallbladders with cholesterol stones. AmJ Physiol 1995;269:659–665.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin

    Matthew I. Goldblatt M.D., Deborah A. Swartz-Basile Ph.D., Carol L. Svatek B.S., Atilla Nakeeb M.D. & Henry A. Pitt M.D.

Authors
  1. Matthew I. Goldblatt M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Deborah A. Swartz-Basile Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Carol L. Svatek B.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Atilla Nakeeb M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Henry A. Pitt M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Henry A. Pitt M.D..

Additional information

Supported by grant RO1-DK442 79–07 from the National Institutes of Health.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goldblatt, M.I., Swartz-Basile, D.A., Svatek, C.L. et al. Decreased gallbladder response in leptin-deficient obese mice. J Gastrointest Surg 6, 438–444 (2002). https://doi.org/10.1016/S1091-255X(01)00046-4

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1016/S1091-255X(01)00046-4

Key words

Search

Navigation